Device Industry Urges CMS To Protect Use Of Medical Innovations In ACO Program
This article was originally published in The Gray Sheet
Executive Summary
In an attempt to prevent accountable care organizations from stifling medtech innovation, medical device groups are calling for widespread changes to a Medicare Shared Savings Program proposal unveiled earlier this spring.
You may also be interested in...
Medtech Companies Advised To Revamp Marketing Strategies To Target ACOs
Life science companies that are able to adapt their marketing practices to the changing health care delivery system within the next one to three years will have a market advantage, say the authors of a June 29 white paper.
Medtech Companies Advised To Revamp Marketing Strategies To Target ACOs
Life science companies that are able to adapt their marketing practices to the changing health care delivery system within the next one to three years will have a market advantage, say the authors of a June 29 white paper.
CMS Officials Tackling Widespread Concerns Over Accountable Care Regulations
Centers for Medicare & Medicaid Services officials acknowledged the challenges health care industry stakeholders face in embracing accountable care organizations while federal regulations governing the program are still in flux.